hydroxyurea has been researched along with Acute Lymphoid Leukemia in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 7.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| " Although he was treated with prednisolone and hydroxyurea, marked eosinophilia persisted and lymphoblasts gradually increased in the bone marrow." | 4.78 | Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia. ( Sanada, M; Takai, K, 1991) |
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 3.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "Hydroxyurea was implicated in 51% of cases." | 2.44 | Dermatomyositis induced by drug therapy: a review of case reports. ( Gottlieb, AB; Seidler, AM, 2008) |
| "The hydroxyurea-induced increase in transferrin receptor was abrogated by transferrin-iron." | 1.29 | Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis. ( Chitambar, CR; Wereley, JP, 1995) |
| "Essential thrombocythemia is a myeloproliferative disorder that infrequently evolves into acute leukemia." | 1.29 | Acute lymphoblastic leukemia in a case of essential thrombocythemia. ( Litz, CE; Woronzoff-Dashkoff, KK, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Easmon, J | 1 |
| Pürstinger, G | 1 |
| Heinisch, G | 1 |
| Roth, T | 1 |
| Fiebig, HH | 1 |
| Holzer, W | 1 |
| Jäger, W | 1 |
| Jenny, M | 1 |
| Hofmann, J | 1 |
| Aygun, B | 1 |
| Seidler, AM | 1 |
| Gottlieb, AB | 1 |
| Li, QB | 1 |
| Li, L | 1 |
| You, Y | 1 |
| Chen, ZC | 1 |
| Xia, LH | 1 |
| Zou, P | 1 |
| Mathews, CK | 1 |
| Efferth, T | 1 |
| Sauerbrey, A | 1 |
| Steinbach, D | 1 |
| Gebhart, E | 1 |
| Drexler, HG | 1 |
| Miyachi, H | 1 |
| Chitambar, CR | 3 |
| Becker, CM | 1 |
| Zintl, F | 1 |
| Humeny, A | 1 |
| Inhorn, RC | 1 |
| Aster, JC | 1 |
| Roach, SA | 1 |
| Slapak, CA | 1 |
| Soiffer, R | 1 |
| Tantravahi, R | 1 |
| Stone, RM | 1 |
| Wereley, JP | 1 |
| Chamberlain, MC | 1 |
| Xu, YZ | 1 |
| Plunkett, W | 1 |
| Woronzoff-Dashkoff, KK | 1 |
| Litz, CE | 1 |
| Higashigawa, M | 1 |
| Hori, H | 1 |
| Hirayama, M | 1 |
| Kawasaki, H | 1 |
| Ido, M | 1 |
| Azuma, E | 1 |
| Sakurai, M | 1 |
| Myette, MS | 1 |
| Elford, HL | 1 |
| Savage, DG | 1 |
| Antman, KH | 1 |
| Takai, K | 1 |
| Sanada, M | 1 |
| Karlsson, A | 1 |
| Reichard, P | 1 |
| Eckstein, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomised Multicentre Phase IV Study to Compare Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec® in Combination With Interferon Alpha at Low Doses in the Treatment of Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukaemia[NCT00390897] | Phase 4 | 360 participants | Interventional | 2003-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for hydroxyurea and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Dermatomyositis induced by drug therapy: a review of case reports.
Topics: Adult; Aged; Antibodies, Antinuclear; Autoimmune Diseases; Cyclophosphamide; Dermatomyositis; Etopos | 2008 |
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot | 1995 |
Imatinib mesylate--a new oral targeted therapy.
Topics: Administration, Oral; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Resistance; | 2002 |
Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.
Topics: Adult; Blood Proteins; Endocardium; Endomyocardial Fibrosis; Eosinophil Granule Proteins; Eosinophil | 1991 |
12 other studies available for hydroxyurea and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines.
Topics: Antineoplastic Agents; Apoptosis; Body Weight; Burkitt Lymphoma; Carcinoma, Large Cell; Cell Cycle; | 2001 |
Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa?
Topics: Africa; Anemia, Sickle Cell; Antisickling Agents; Child; Humans; Hydroxyurea; Precursor Cell Lymphob | 2020 |
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combine | 2009 |
DNA synthesis as a therapeutic target: the first 65 years.
Topics: Aminopterin; Antimetabolites, Antineoplastic; DNA Replication; Fluorouracil; Folic Acid; Folic Acid | 2012 |
Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control St | 2003 |
Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
Topics: Antineoplastic Agents; DNA; Ferritins; Gene Expression Regulation; Humans; Hydroxyurea; Iron; Iron-R | 1995 |
Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; C | 1994 |
Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells.
Topics: Aphidicolin; Carbon Radioisotopes; Cell Cycle; Cytarabine; Deoxycytidine; Deoxyuridine; DNA Replicat | 1993 |
Acute lymphoblastic leukemia in a case of essential thrombocythemia.
Topics: Aged; Antigens, CD; Blast Crisis; Bone Marrow; Female; Humans; Hydroxyurea; Lymphocyte Activation; P | 1996 |
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Co | 1997 |
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Topics: Antineoplastic Agents; Benzamidines; Cell Division; Deoxycytidine; Drug Synergism; Enzyme Inhibitors | 1998 |
The metabolism of 3'-azido-2',3'-dideoxyguanosine in CEM cells.
Topics: Antiviral Agents; Cell Line; Deoxyribonucleotides; Dideoxynucleosides; DNA, Neoplasm; Humans; Hydrox | 1990 |